Developer docs
API playgroundTry for free, no card

Search company profiles

Rosco Diagnostica

Full company profile

uuid0034xqt

Namestring
Rosco Diagnostica
Legal namestring
Rosco Diagnostica ApS
Company typeenum
Private
Founded yearint
1970
Descriptiontext

Rosco Diagnostica is a privately held Danish in vitro diagnostics (IVD) manufacturer founded in 1970 and headquartered in Albertslund, Denmark. The company specializes in diagnostic products for clinical microbiology laboratories focused on bacterial and fungal identification and antimicrobial susceptibility testing — explicitly positioned to aid in the fight against antibiotic resistance. Its core portfolio comprises three product lines: Neo-Sensitabs (125+ crystalline antimicrobial and antifungal tablets for disc-diffusion susceptibility testing), Diatabs (80+ enzymatic and conventional tablets for 4-hour bacterial/fungal identification), and Rosco Kits (rapid colorimetric and phenotypic detection kits for ESBL, AmpC, and carbapenemase resistance mechanisms). The proprietary Neo-Sensitabs dry-process crystalline formulation delivers controlled antibiotic release, room-temperature stability, and optical code readability that distinguish it from traditional paper-disc methods. Products are CE-marked under EU IVD Directive 98/79/EC, with documentation maintained to REACH standards.

Rosco operates a B2B sales-led GTM motion, distributing through a network of authorized distributors in more than 50 countries as well as direct sales to hospital laboratories and national health systems. It targets clinical microbiology laboratories, hospitals, distributors, national health surveillance bodies, and (with an expanding veterinary line) veterinary clinics. Marketing relies on a content-rich website, technical documentation (IFU, COA, MSDS), and annual participation at MEDICA (Düsseldorf) and ESCMID (Vienna). Pricing is quote-based and not publicly disclosed; product sales function as one-time consumable transactions (physical diagnostic tablets and kits) rather than subscription or licensing revenue. The company was fully acquired by Alpine-bio on February 29, 2024, and operates with 11–50 employees. Rosco's underlying business model is mature and cash-generative in profile, but small in scale relative to automated susceptibility platforms, with growth dependent on catalog breadth (new antimicrobials, veterinary expansion) and distributor network deepening rather than disruptive technology cycles.

Short descriptiontext

Rosco Diagnostica is a Danish IVD manufacturer producing Neo-Sensitabs, Diatabs, and resistance-detection kits for clinical microbiology laboratories, hospitals, distributors, and veterinary clinics in over 50 countries, specializing in antibiotic susceptibility testing and bacterial identification to combat antibiotic resistance.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersAlbertslund, Denmark
HQ citystring
Albertslund
HQ countrystring
Denmark
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
antimicrobial susceptibility testing, bacterial identification diagnostics, antibiotic resistance detection, in-vitro diagnostic tablets, clinical microbiology reagents
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In-vitro clinical microbiology diagnostics
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Diagnostic Products Sales
TypeOne Time License
Description

Sale of diagnostic products including Neo-Sensitabs for susceptibility testing, Diatabs for bacterial identification, kits for resistance mechanism detection, reagents, and accessories to clinical laboratories, hospitals, and distributors worldwide.

rosco-diagnostica.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Direct sales to end customers
ModelOtherBilling cadencePay-as-you-go
Notes

Products available through direct sales; distributors serve as channel partners in international markets.

rosco-diagnostica.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Diatabs
Description

Diagnostic tablets for rapid identification of Bacteria and Fungi

rosco-diagnostica.com
+2 more records
Core offering1 text field

Rosco Diagnostica manufactures and sells in-vitro diagnostic tablets and kits used by clinical microbiology laboratories for bacterial and fungal identification and antimicrobial susceptibility testing. Its portfolio comprises Neo-Sensitabs (over 125 antimicrobial and antifungal susceptibility testing tablets), Diatabs (over 80 rapid enzymatic identification tests with 4-hour results), and Rosco Kits for detecting resistance mechanisms such as ESBLs, AmpC, and carbapenemases via rapid colorimetric and phenotypic methods. Supporting accessories include tablet dispensers for various Petri dish formats.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Rapid identification in 4 hours using Diatabs enzymatic tests
+3 more records
Product overview1 text field

Rosco Diagnostica offers a diagnostic product portfolio consisting of three main product lines: Neo-Sensitabs (antibiotic and antifungal susceptibility testing tablets with over 125 agents), Diatabs (bacterial and fungal identification with over 80 individual tests), and Kits for detection of resistance mechanisms (rapid colorimetric and phenotypic methods for ESBL, AmpC, carbapenemases). The products work together to enable clinical microbiology laboratories to perform complete antimicrobial susceptibility testing and bacterial identification workflows. Supporting accessories include dispensers for various plate sizes. The company also offers specialized veterinary products and reagents.

Product and service5 records
1Neo-Sensitabs
CategorySusceptibility testing tablets
Description

Antibiotic and antifungal susceptibility testing tablets for clinical microbiology laboratories, manufactured using a proprietary dry-process crystalline antimicrobial formulation that provides controlled antibiotic release into agar, long shelf life at room temperature, and large-print 5-figure codes for identification. Available in over 125 different antimicrobial agents and combination tablets, with dedicated ranges for routine susceptibility testing, veterinary use, and antifungal testing, and compatible with CLSI and EUCAST guidelines.

2Diatabs
CategoryBacterial and fungal identification tablets
Description

Rapid bacterial and fungal identification system based on microbial enzyme profiles, offering over 80 individual enzymatic and modified conventional tests usable as single tests or in combinations. Delivers 4-hour identification results at up to 50% cost savings versus automated systems, with dedicated bacterial identification tests and a reagents range for in-vitro qualitative procedures.

3Rosco Kits for Detection of Resistance Mechanisms
CategoryResistance mechanism detection kits
Description

Ready-to-use kits for detecting ESBLs, AmpC, and carbapenemases (KPC and metallo-β-lactamases) in bacterial isolates. Includes rapid colorimetric kits delivering results in 15 minutes to 1 hour (Rapid ESBL Screen Kit, Rapid BLUE CARB Kit, Neo-Rapid CARB Kit) and 18-hour phenotypic confirmatory kits (KPC/MBL Confirm Kit, AmpC Confirm Kit, ESBL+AmpC Screen Kit, Triple disk for KPC+MBL, ESBL Confirm Kits, Total MBL Confirm Kit, Total ESBL+AmpC Confirm Kit, and KPC/MBL in P.aeruginosa/Acinetobacter Kit).

4Tablet Dispensers (Accessories)
5Special Products
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spanish manufacturer of microbiology products including antimicrobial susceptibility discs and identification systems. Closely comparable specialty manufacturer competing in the same manual susceptibility testing segment as Rosco.

TypeDirect peer
Description

European diagnostics company offering microbiology reagents, susceptibility testing products, and identification systems. Directly comparable in product portfolio and target customer segment to Rosco Diagnostica.

TypeBroad incumbent
Description

Major diagnostics incumbent offering the BD Phoenix automated susceptibility system and manual microbiology products. Targets the same clinical microbiology lab customers as Rosco and competes across both manual and automated susceptibility workflows.

TypeBroad incumbent
Description

Offers the MicroScan automated identification and susceptibility testing system for clinical microbiology labs. Competes with Rosco in the same hospital lab segment and represents the automated alternative to Rosco's manual disc-diffusion approach.

TypeBroad incumbent
Description

Global leader in microbiology diagnostics, offering automated identification and susceptibility testing systems (e.g., Vitek 2) alongside a broad manual product portfolio that directly overlaps with Rosco's Neo-Sensitabs and Diatabs offerings for clinical microbiology labs.

TypeDirect peer
Description

Italian manufacturer of antibiotic susceptibility discs, identification strips, and MIC strips for clinical microbiology. Directly competes with Rosco's Neo-Sensitabs in disc-diffusion antimicrobial testing and shares the same customer base of hospital and reference laboratories.

TypeBroad incumbent
Description

Diversified life sciences giant supplying microbiology consumables, identification panels, and antimicrobial susceptibility products (e.g., Sensititre). Competes broadly with Rosco across manual and automated susceptibility testing workflows.

TypeDirect peer
Description

US manufacturer and distributor of microbiology products including culture media, susceptibility discs, and identification reagents. Comparable niche specialty manufacturer serving clinical microbiology labs with manual testing consumables.

TypeDirect peer
Description

UK-based manufacturer of antimicrobial susceptibility discs, identification strips, and culture media for clinical microbiology. Direct peer with similar product format (discs/tablets) and overlapping customer base in hospital microbiology labs.

TypeDirect peer
Description

Provides microbiology quality controls and identification/susceptibility testing reagents, including disc-based products. Directly comparable to Rosco in serving clinical microbiology labs with manual susceptibility testing consumables.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rosco Diagnostica

In-vitro clinical microbiology diagnosticsrosco-diagnostica.com

Rosco Diagnostica is a Danish IVD manufacturer producing Neo-Sensitabs, Diatabs, and resistance-detection kits for clinical microbiology laboratories, hospitals, distributors, and veterinary clinics in over 50 countries, specializing in antibiotic susceptibility testing and bacterial identification to combat antibiotic resistance.

What Rosco Diagnostica does

Rosco Diagnostica is a privately held Danish in vitro diagnostics (IVD) manufacturer founded in 1970 and headquartered in Albertslund, Denmark. The company specializes in diagnostic products for clinical microbiology laboratories focused on bacterial and fungal identification and antimicrobial susceptibility testing — explicitly positioned to aid in the fight against antibiotic resistance. Its core portfolio comprises three product lines: Neo-Sensitabs (125+ crystalline antimicrobial and antifungal tablets for disc-diffusion susceptibility testing), Diatabs (80+ enzymatic and conventional tablets for 4-hour bacterial/fungal identification), and Rosco Kits (rapid colorimetric and phenotypic detection kits for ESBL, AmpC, and carbapenemase resistance mechanisms). The proprietary Neo-Sensitabs dry-process crystalline formulation delivers controlled antibiotic release, room-temperature stability, and optical code readability that distinguish it from traditional paper-disc methods. Products are CE-marked under EU IVD Directive 98/79/EC, with documentation maintained to REACH standards.

Rosco operates a B2B sales-led GTM motion, distributing through a network of authorized distributors in more than 50 countries as well as direct sales to hospital laboratories and national health systems. It targets clinical microbiology laboratories, hospitals, distributors, national health surveillance bodies, and (with an expanding veterinary line) veterinary clinics. Marketing relies on a content-rich website, technical documentation (IFU, COA, MSDS), and annual participation at MEDICA (Düsseldorf) and ESCMID (Vienna). Pricing is quote-based and not publicly disclosed; product sales function as one-time consumable transactions (physical diagnostic tablets and kits) rather than subscription or licensing revenue. The company was fully acquired by Alpine-bio on February 29, 2024, and operates with 11–50 employees. Rosco's underlying business model is mature and cash-generative in profile, but small in scale relative to automated susceptibility platforms, with growth dependent on catalog breadth (new antimicrobials, veterinary expansion) and distributor network deepening rather than disruptive technology cycles.

Rosco Diagnostica firmographics

Firmographics
Name
Rosco Diagnostica
Legal name
Rosco Diagnostica ApS
Website
https://rosco-diagnostica.com
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
11–50 employees
Short description
Rosco Diagnostica is a Danish IVD manufacturer producing Neo-Sensitabs, Diatabs, and resistance-detection kits for clinical microbiology laboratories, hospitals, distributors, and veterinary clinics in over 50 countries, specializing in antibiotic susceptibility testing and bacterial identification to combat antibiotic resistance.
Ownership category
akta.pro rank

Where Rosco Diagnostica is headquartered

Location

Headquarters

HQ city
Albertslund
HQ country
Denmark
HQ region
Europe

Offices1 record

Markets served

Rosco Diagnostica business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Diagnostic Products Sales: Sale of diagnostic products including Neo-Sensitabs for susceptibility testing, Diatabs for bacterial identification, kits for resistance mechanism detection, reagents, and accessories to clinical laboratories, hospitals, and distributors worldwide.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goDirect sales to end customers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Rosco Diagnostica product offering

Product offering

Core offering

Rosco Diagnostica manufactures and sells in-vitro diagnostic tablets and kits used by clinical microbiology laboratories for bacterial and fungal identification and antimicrobial susceptibility testing. Its portfolio comprises Neo-Sensitabs (over 125 antimicrobial and antifungal susceptibility testing tablets), Diatabs (over 80 rapid enzymatic identification tests with 4-hour results), and Rosco Kits for detecting resistance mechanisms such as ESBLs, AmpC, and carbapenemases via rapid colorimetric and phenotypic methods. Supporting accessories include tablet dispensers for various Petri dish formats.

Product overview

Rosco Diagnostica offers a diagnostic product portfolio consisting of three main product lines: Neo-Sensitabs (antibiotic and antifungal susceptibility testing tablets with over 125 agents), Diatabs (bacterial and fungal identification with over 80 individual tests), and Kits for detection of resistance mechanisms (rapid colorimetric and phenotypic methods for ESBL, AmpC, carbapenemases). The products work together to enable clinical microbiology laboratories to perform complete antimicrobial susceptibility testing and bacterial identification workflows. Supporting accessories include dispensers for various plate sizes. The company also offers specialized veterinary products and reagents.

Differentiator

Problem solved

Functional benefit

Brands

  • Diatabs: Diagnostic tablets for rapid identification of Bacteria and Fungi
  • Neo-Sensitabs
  • ROSCO KITS

Products and services

  • Neo-Sensitabs Antibiotic and antifungal susceptibility testing tablets for clinical microbiology laboratories, manufactured using a proprietary dry-process crystalline antimicrobial formulation that provides controlled antibiotic release into agar, long shelf life at room temperature, and large-print 5-figure codes for identification. Available in over 125 different antimicrobial agents and combination tablets, with dedicated ranges for routine susceptibility testing, veterinary use, and antifungal testing, and compatible with CLSI and EUCAST guidelines.
  • Diatabs Rapid bacterial and fungal identification system based on microbial enzyme profiles, offering over 80 individual enzymatic and modified conventional tests usable as single tests or in combinations. Delivers 4-hour identification results at up to 50% cost savings versus automated systems, with dedicated bacterial identification tests and a reagents range for in-vitro qualitative procedures.
  • Rosco Kits for Detection of Resistance Mechanisms Ready-to-use kits for detecting ESBLs, AmpC, and carbapenemases (KPC and metallo-β-lactamases) in bacterial isolates. Includes rapid colorimetric kits delivering results in 15 minutes to 1 hour (Rapid ESBL Screen Kit, Rapid BLUE CARB Kit, Neo-Rapid CARB Kit) and 18-hour phenotypic confirmatory kits (KPC/MBL Confirm Kit, AmpC Confirm Kit, ESBL+AmpC Screen Kit, Triple disk for KPC+MBL, ESBL Confirm Kits, Total MBL Confirm Kit, Total ESBL+AmpC Confirm Kit, and KPC/MBL in P.aeruginosa/Acinetobacter Kit).
  • Tablet Dispensers (Accessories)
  • Special Products

Quantifiable outcome

  • Rapid identification in 4 hours using Diatabs enzymatic tests
  • +3 more outcomes

Companies that use Rosco Diagnostica

Customer profile

Segments5 records

Ideal customer profiles4 records

Rosco Diagnostica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Rosco Diagnostica partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Rosco Diagnostica competitors and assessment

Company assessment

Direct peers

  • Condalab: Spanish manufacturer of microbiology products including antimicrobial susceptibility discs and identification systems. Closely comparable specialty manufacturer competing in the same manual susceptibility testing segment as Rosco.
  • ELITech Group: European diagnostics company offering microbiology reagents, susceptibility testing products, and identification systems. Directly comparable in product portfolio and target customer segment to Rosco Diagnostica.
  • Liofilchem: Italian manufacturer of antibiotic susceptibility discs, identification strips, and MIC strips for clinical microbiology. Directly competes with Rosco's Neo-Sensitabs in disc-diffusion antimicrobial testing and shares the same customer base of hospital and reference laboratories.
  • Hardy Diagnostics: US manufacturer and distributor of microbiology products including culture media, susceptibility discs, and identification reagents. Comparable niche specialty manufacturer serving clinical microbiology labs with manual testing consumables.
  • Mast Group: UK-based manufacturer of antimicrobial susceptibility discs, identification strips, and culture media for clinical microbiology. Direct peer with similar product format (discs/tablets) and overlapping customer base in hospital microbiology labs.
  • Bio-Rad Laboratories: Provides microbiology quality controls and identification/susceptibility testing reagents, including disc-based products. Directly comparable to Rosco in serving clinical microbiology labs with manual susceptibility testing consumables.

Broad incumbents

  • Becton Dickinson (BD): Major diagnostics incumbent offering the BD Phoenix automated susceptibility system and manual microbiology products. Targets the same clinical microbiology lab customers as Rosco and competes across both manual and automated susceptibility workflows.
  • Beckman Coulter (Danaher): Offers the MicroScan automated identification and susceptibility testing system for clinical microbiology labs. Competes with Rosco in the same hospital lab segment and represents the automated alternative to Rosco's manual disc-diffusion approach.
  • bioMérieux: Global leader in microbiology diagnostics, offering automated identification and susceptibility testing systems (e.g., Vitek 2) alongside a broad manual product portfolio that directly overlaps with Rosco's Neo-Sensitabs and Diatabs offerings for clinical microbiology labs.
  • Thermo Fisher Scientific: Diversified life sciences giant supplying microbiology consumables, identification panels, and antimicrobial susceptibility products (e.g., Sensititre). Competes broadly with Rosco across manual and automated susceptibility testing workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Rosco Diagnostica compliance and trust

Trust signal

Compliance1 record

Rosco Diagnostica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rosco Diagnostica leadership team

Management profile

Number of profiles

Profiles1 record

Rosco Diagnostica funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rosco Diagnostica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rosco Diagnostica

What does Rosco Diagnostica do?

Rosco Diagnostica manufactures and sells in-vitro diagnostic tablets and kits used by clinical microbiology laboratories for bacterial and fungal identification and antimicrobial susceptibility testing. Its portfolio comprises Neo-Sensitabs (over 125 antimicrobial and antifungal susceptibility testing tablets), Diatabs (over 80 rapid enzymatic identification tests with 4-hour results), and Rosco Kits for detecting resistance mechanisms such as ESBLs, AmpC, and carbapenemases via rapid colorimetric and phenotypic methods. Supporting accessories include tablet dispensers for various Petri dish formats.

Is Rosco Diagnostica a public or private company?

Rosco Diagnostica is a private company. It is classified as corporate owned and is currently operating.

When was Rosco Diagnostica founded?

Rosco Diagnostica was founded in 1970. It employs 11 to 50 people.

Where is Rosco Diagnostica based?

Rosco Diagnostica is headquartered in Albertslund, Denmark, in the Europe region.

How does Rosco Diagnostica make money?

One revenue line is on record: diagnostic Products Sales.

Who are Rosco Diagnostica's main competitors?

Direct peers on record are Condalab, ELITech Group, Liofilchem, Hardy Diagnostics, Mast Group and Bio-Rad Laboratories. Broad incumbents are Becton Dickinson (BD), Beckman Coulter (Danaher), bioMérieux and Thermo Fisher Scientific.

Does Rosco Diagnostica have an API?

No public API is recorded for Rosco Diagnostica.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales